Sevelamer Hydrochloride Tablet
Product Images NDC 70748-173
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 70748-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
02 (0572e0ce 920f 4db8 8db1 049e577aaadc 02)
03 (0572e0ce 920f 4db8 8db1 049e577aaadc 03)
06 (0572e0ce 920f 4db8 8db1 049e577aaadc 04)
Each tablet contains 400mg of Sevelamer hydrochloride manufactured by Lupin Pharmaceuticals, NDC 70748-172-27 in Baltimore, Maryland, USA. The dosage information is available in the package insert for the United States. The medication should be dispensed in a tight container and stored between 15°C to 30°C (59°F to 86°F) in Nagpur, India. This medication is intended for prescription use only, and each package contains 360 tablets.*
07 (0572e0ce 920f 4db8 8db1 049e577aaadc 05)
This is a medication description for Sevelamer hydrochloride tablets containing 800mg of the active ingredient. There are 180 tablets in the container manufactured by Lupin Pharmaceuticals, Inc. The usual dosage is available in the package insert. The tablets should be dispensed in a tight container and protected from temperature excursions of 15° to 30°C (59° to 86°F). The tablet dimensions are 170% and 78mm while the code number is MHIDRUGS25-ND/59 with dimensions of 81x35 mm. The unvarnished area of the description is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.